Merck KGaA
Merck KGaA is a German science and technology enterprise operating across healthcare, life sciences, and performance materials sectors. The company develops and manufactures prescription biopharmaceuticals for oncology and immunology, laboratory supplies and re-agents for biomedical research, and specialty chemicals for semiconductor manufacturing. Its operational structure comprises three global divisions: Healthcare, Life Science, and Electronics. Revenues are derived from sales of specialty pharmaceutical therapies, bioprocess technologies, laboratory reagents, and semiconductor performance chemicals globally. Merck KGaA holds a leading market position as a key global supplier to the pharmaceutical and semiconductor industries. The company is headquartered in Darmstadt, Germany, and its capital shares trade on the Frankfurt Stock Exchange.
64 of the funds FundTelligence covers report a position in Merck KGaA.
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 64
- Exposure themes
- Reproductive health, Treatment, Women's Health
Funds holding Merck KGaA
- Schroder ISF EURO Equity — Schroders · 2.57 % (full portfolio disclosed, June 2026)
- Schroder ISF European Sustainable Equity — Schroders · 2.2 % (full portfolio disclosed, June 2026)
- BNP Euro Equity — BNP Paribas · 2.18 % (full portfolio disclosed, June 2026)
- Schroder ISF European Dividend Maximiser — Schroders · 1.72 % (full portfolio disclosed, June 2026)
- T. Rowe Price European Equity Fund — T. Rowe Price · 1.58 % (full portfolio disclosed, September 2026)
- BNP Europe Equity — BNP Paribas · 1.56 % (full portfolio disclosed, December 2025)
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 1.08 % (full portfolio disclosed, October 2026)
- DNB Fund Women's Health — DNB · 1.01 % (full portfolio disclosed, August 2026)
Showing the 8 largest of 64 funds holding it.